Same pandemic but different studies: an exploration of COVID-19 research at the early stage.
Eur Rev Med Pharmacol Sci
; 24(23): 12545-12557, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-995015
ABSTRACT
OBJECTIVE:
Scientific research is an essential necessity for the prevention and control of COVID-19. Accelerated paper-sharing makes it possible to explore the responses of scientific communities of different countries and their research focus. This is achieved by examining relevant publications during the early stage of the pandemic. This paper explores a timely research assessment on COVID-19 among China, USA, and EU. MATERIALS ANDMETHODS:
Papers indexed in PubMed and published from December 30, 2019, to March 11, 2020, were selected. Papers from China, USA, and EU were assessed by calculating the significance of items in the co-occurrence exported from VOSviewer.RESULTS:
The results showed that Chinese studies focus more on clinical manifestations, while USA and EU focus on experimental research. Furthermore, US research is more geared toward detection techniques and mathematical models, China focuses more on monitoring the epidemic situation, and EU engages in both.CONCLUSIONS:
This paper argues that the above distinctions are caused by differences in the stages of epidemic development, researchers' experience bases for formulating measures, traditions within the different medical cultures, and the distinction between "information" and "knowledge".
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Biomedical Research
/
Internationality
/
COVID-19 Drug Treatment
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Reviews
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
North America
/
Asia
Language:
English
Journal:
Eur Rev Med Pharmacol Sci
Journal subject:
Pharmacology
/
Toxicology
Year:
2020
Document Type:
Article
Affiliation country:
Eurrev_202012_24052
Similar
MEDLINE
...
LILACS
LIS